In the study of colon cancer, ETBF-produced BFT impairs colonic epithelium and barrier integrity leading to oncogenic Th17-dominated inflammation, which induces epithelial cell proliferation through activation of NF-KB, STA3 signaling pathways and promotes cancer development [39]. This evidence concerns the gene NFKB1 and colonic neoplasm.